Superbugs Are Getting Stronger. Our Defenses Are Getting Weaker
By David Thomas and Emily Wheeler
Drug-resistant infections pose a growing threat to public health. We're not prepared to meet it.
That's because the pipeline of new antibiotics to fend off superbugs has fallen off. Superbugs are strains of bacteria and fungi that have developed immunity to the medicines used to kill them. Antimicrobials are critical tools in our fight against these pathogens.
The problem is that we're not developing nearly enough of them and many of the medicines we have are no longer effective. It's imperative that we act now to bolster our defenses against these serious and life-threatening infections.
There are only 64 antibacterial therapeutics currently in clinical development. That's compared to 1,300 treatments in development for various cancers.
The antibacterial pipeline is shrinking. In the last 35 years, just one antibacterial with a novel way to target bacteria has been approved.
Meanwhile, superbugs continue to grow stronger. New research estimates they claimed 1.27 million lives in 2019 -- more than twice the estimated number of annual deaths just five years prior.
Why is our development of new antibacterials declining while new pathogens are on the rise?
The problem is not the lack of success in developing new treatments. In the past decade, antibacterial drugs in clinical trials were twice as likely to move from early human testing to FDA approval versus drugs for all other diseases.
Instead, the problem is a misaligned market for antimicrobials.
Take the experience of the biotech firm Achaogen, which secured FDA approval in 2018 for its novel antibiotic plazomicin after 15 years of development.
While important for the overall armamentarium, novel antimicrobials are used sparingly to prevent pathogens from developing resistance to our strongest medications. As a result, clinicians hold novel antibiotics in reserve, using them judiciously to preserve effectiveness. That means companies like Achaogen don't sell large quantities of the drugs they develop -- or earn back the capital they invested in research and development.
Achaogen filed for bankruptcy in 2019. In the three years since, several other small biotech companies have seen a similar fate.
The market conditions are so discouraging that most large biopharmaceutical companies have pulled out of the sector entirely. These dynamics are causing investors to vacate the antimicrobial sector, too.
If nothing changes, 10 million people worldwide could die of drug-resistant infections annually by 2050 -- surpassing cancer as a leading cause of death.
Government intervention and incentives can help change the game for private companies to develop these medications.
One solution is the bipartisan, bicameral Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act, which would change the current dose-based payment model for certain antimicrobials. Under PASTEUR, the government would offer developers of critically needed antimicrobials between $750 million and $3 billion up front in exchange for access to their medications once they hit the market. This approach provides developers with the predictable return on investment needed to fuel much-needed antimicrobial innovation.
Another bill under consideration is the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act. The legislation would increase Medicare reimbursements for certain antimicrobials, ensuring patients have access to the best novel antibiotics for their individual needs.
Superbugs are here to stay. We have policy solutions on the table that can help prevent them from taking a growing number of lives. It's long past time to take action.
David Thomas, MS, is vice president of industry research at the Biotechnology Innovation Organization. Emily Wheeler is director of infectious disease policy at the Biotechnology Innovation Organization. A version of this piece originally ran in MedPage Today.
More Resources
Unable to open RSS Feed $XMLfilename with error HTTP ERROR: 404, exiting
More Medicine Information:
Related Articles
Over The Counter Pain Medication: How To Choose The Right Drugs
With the recent front-page news about the possible hazards of pain medications, you may be taking a look at your over-the-counter (or OTC) pain medications with a wary eye. While all drugs, including those you don't need a prescription for, can be dangerous, some basic knowledge can help you avoid the pitfalls for the pain relief you need.
Hidden ER Costs Undermine Health Markets
Imagine you're traveling in a different state when, suddenly, you begin to feel severe abdominal pain. Being unfamiliar with the area and wanting to avoid hefty out-of-network bills, you call your insurance company to find an in-network hospital.
Benign Tumors Of The Cervix
Endocervical polypsEndocervical polyps are the most common benign neoplasms of the cervix. Please note that the word neoplasm refers to a cancerous growth.
Top Five FAQs About Nail Fungus
What is nail fungus?Nail fungus, also known as Onychomycosis, is an organism which digests the keratin found in your fingernails and toenails. The fingernail and toenail are naturally built to be strong barriers, and resistant to fungi and other infections.
Medical Tourism Opportunities in India
More and more people have started travelling to India for Medical Treatment and during the past year alone, over 150000 people travelled to India for their medical requirements. Medical Tourism is finally coming of age.
The Truth about C Reactive Protein and Cholesterol Lowering Drugs
You might disagree, but hear me out on this..
A Compelling Look at Pain Relief
If your back aches when you're loading groceries in the car or your hands cramp up with arthritis when you sit down at the computer, you're not alone. Although the nature, cause, and complaints vary, over one-half of Americans experience chronic or recurrent pain, a recent survey conducted by the Stanford University Medical Center found.
Toenail Fungus: Treatment and Prevention
A thick, yellowish nail with splotchy white areas is a classic presentation for a fungal toenail. In the early stages the toenail is only slightly discolored, or slightly thickened.
Traditional Treatments for Back Pain... Which Ones Work and Which Ones Don't?
When Dorothy followed the yellow brick road, she was told to do so by those who wanted her to get where she wanted go. Well as humans when we blindly follow recommendations even by individuals who have good intentions, it may not always be your best option.
Bee Propolis: Synergisitc Health Care for the 21st Centruy
For well over a century modern science has progressed at a startling rate. With this increase in knowledge has come medicinal and healthcare benefits that have seen ages peak and diseases eradicated.
Mind Altering
"It's a chemical imbalance." I've heard those words so many times in the last decade, it's becoming routine for Doctors to blame everything on it.
Kids and Medication Part I
We have all talked a lot about the problems in our educational system, about latchkey kids, about teacher turnover (50 percent of teachers quitted within the first five years on the job), psychologists over prescribing medications such as Prozac and Ritalin with our friends and families. We can all foresee a terrible problem in the future because we are feeding these drugs to kids under the age of six, their brains have not been fully formed yet and these drugs and their predecessors and competing drugs all have adverse side effects.
Serevent Side Effects Put Serevent in Top 5 Most Dangerous Drugs
Serevent is an asthma inhalation medication, a bronchodilator, that relaxes the muscles in airways. It is preventative and not effective when taken during an asthma attack.
The Power of Ice
Using ice to treat injuries is one of the oldest methods of pain control. Proven to be safe and effective at reducing swelling, relieving pain and decreasing muscle spasms, ice therapy is an easy self-care technique that anyone can administer.
What Not to Tell Your Doctor?
For many years since medicine has been established as anethical profession and gained widespread credence peoplehave believed that they could and should tell their doctoreverything even remotely pertinent to their health and thatit was held in the strictest confidence. Furthermore, howcan the physician make accurate judgments when important orsignificant information is missing? This system worked verywell until relatively recently but there now exists a breachof this confidence that people should know about and thisbreach has developed from the advent of third partyinvestigations into people's backgrounds.
Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers
Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently.
Protopic Cancer Risk Lawyer
The FDA issued a warning in July of 2005 on two skin creams, Elidel (pimecrolimus) and Protopic (tacrolimus) to all ages. Recent animal studies have found that Protopic causes lymphomas and skin cancers in an unknown percentage of users.
Melatonin, Sleep Enhancement, and ADHD
OverviewMelatonin is a natural hormone, which is produced and secreted by the pineal gland. Melatonin plays an important role in the regulation of many hormones in the body.
Bulk Forming Drugstore Laxatives
There are five basic types of drugstore laxatives you should be aware of. Some of these laxatives can be dangerous to use.
Sinusitis: Sinus Infection Deals a Corporate KO
Sinusitis and Sinus Infection Starts with a Little SniffleYes, I hear it too. A simple sniffle in a distant cubical.
Cetyl Myristoleate for Arthrtis: Science or Speculation
There are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across the Internet. Mine is one of them.